![](https://www.e-med.co.il/wp-content/uploads/2022/06/default-312x200.jpg)
AstraZeneca Receives FDA Approval For Faslodex – A New Type Of Breast Cancer Treatment For Tamoxifen Resistant Breast Cancer
'Faslodex' (fulvestrant) – First of A New Type of Breast Cancer Treatments LONDON, ENGLAND — April 26,
'Faslodex' (fulvestrant) – First of A New Type of Breast Cancer Treatments LONDON, ENGLAND — April 26,
NEW YORK (MedscapeWire) Apr 25 Adding positron emission tomography (PET) scanning to conventional preoperative workup would
from Nutrition and Cancer Aaron T. Fleischauer, Sara H. Olson, Laura Mignone, Neal Simonsen, Thomas A. Caputo,
from Abstracts in Hematology & OncologyTM Huang WY, Newman B, Millikan RC, et al. Am J Epidemiol.
Gynecologic Oncology 04/17/2002 By Elda Hauschildt Oral administration of 5-aminolevulinic acid (5-ALA) allows fluorescence of the cervix
HOUSTON, TX and PHILADELPHIA, PA — April 9, 2002 — Texas Biotechnology Corporation and GlaxoSmithKline announced that
NEW YORK (Reuters Health) Apr 18 – The addition of positron emission tomography (PET) to the routine
Cancer 04/10/2002 By David Loshak Patients with fludarabine-refractory chronic lymphocytic leukaemia and small cell lymphocytic lymphoma often
NEW YORK (Reuters Health) Apr 15 – When breast cancer is diagnosed more than 20 weeks after
NEW YORK (MedscapeWire) Apr 16 More than one-third of patients given brachytherapy for prostate cancer have
נא ציין כתובת דואר אלקטרוני שבה אתה מקבל דיוורי e-Med או זו שציינת בכרטיס האישי שלך.
קישור לאיפוס סיסמא נשלח למייל.
חזרה להתחברות